Cargando…
Immune Check Point Inhibitor–Associated Glomerulonephritis
Autores principales: | Ashour, Tarek, Nakhoul, Georges, Patil, Pradnya, Funchain, Pauline, Herlitz, Leal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6365371/ https://www.ncbi.nlm.nih.gov/pubmed/30775635 http://dx.doi.org/10.1016/j.ekir.2018.10.017 |
Ejemplares similares
-
Immune Check Point Inhibitor–Associated Endothelialitis
por: Bobart, Shane A., et al.
Publicado: (2020) -
Pauci-Immune Crescentic Glomerulonephritis due to Disseminated Histoplasmosis
por: Said, Samar M., et al.
Publicado: (2019) -
Immune-Complex Glomerulonephritis After COVID-19 Infection
por: Sethi, Sanjeev, et al.
Publicado: (2021) -
Beneficial Effect of Rituximab in the Treatment of Esophageal Cancer–Associated Pauci-Immune Glomerulonephritis
por: Ameye, Heleen, et al.
Publicado: (2016) -
Pauci-immune Crescentic Glomerulonephritis Due to MGRS Crystalline Nephropathy
por: Sharma, Shailendra, et al.
Publicado: (2019)